The treatment paradigm for type B dissections is widely debated amongst physicians. In the latest supplement to Endovascular Today Europe, experts from around the globe discuss their approaches to treatment and explore various therapeutic strategies. Read the articles from the supplement below:
Where are we headed with the treatment of type B aortic dissection?
by Christoph A. Nienaber, MD, PhD
Timing of TEVAR treatment
When should treatment occur in acute, initially uncomplicated type B aortic dissection?
by Michael D. Dake, MD
Distal stent graft-induced new entry
The current paradigm and future management of dSINE
by Hung-Lung Hsu, MD; and Chun-Che Shih, MD, PhD
Seeing the signs
The top precursors/predictors for earlier endovascular treatment versus medical management of type B aortic dissection
by Worawong Slisatkorn, MD
Treating complicated acute type B aortic dissection with proximal stent grafts and distal bare stents
Bare aortic stents can expand the true lumen immediately and result in early favorable aortic remodeling
by Jer-Shen Chen, MD
Exploring the use of bare stents in the treatment of type B dissection
Understanding the effects on aortic remodeling and malperfusion
by Jonathan Sobocinski, MD, PhD; Nuno V. Dias, MD, PhD; Rachel Clough, MD, PhD; and Stéphan Haulon, MD, PhD
Toward the uniluminal state
Evolving concepts in the endovascular elimination of aortic dissection
by Peter Mossop, MD; and Ian Nixon, MD
TEVAR for chronic type B aortic dissection
A discussion of therapeutic strategies for chronic type B aortic dissection, avoiding expansion of the false lumen, and treatment with endovascular therapy
by Masaaki Kato, MD
Postdissection aneurysms
Devices and techniques for treating this condition
by George N Kouvelos, MD; Tilo Kölbel, MD, PhD; Athanasios Katsargyris, MD; Nikolaos Tsilimparis, MD, PhD; Kyriakos Oikonomou, MD; and Eric L.G. Verhoeven, MD, PhD